HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Pathology8 papers

Nodular high grade B-cell lymphoma morphology

Last edited: 4/15/2026

Overview

Nodular high-grade B-cell lymphoma is an aggressive subtype of non-Hodgkin lymphoma characterized by a nodular architecture at histopathology, with a predominance of large B-cells and a high proliferation rate 1.

Diagnosis

  • Histopathological examination essential, highlighting nodular pattern and high-grade cytology 1.
  • Immunohistochemistry confirms B-cell lineage, often showing markers like CD19, CD20, and CD10 1.
  • Flow cytometry may aid in assessing clonality and minimal residual disease 1.
  • Electron microscopy not routinely required but can provide ultrastructural details if needed 1.

    • Management

  • First-line treatment typically involves intensive chemotherapy regimens such as CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) or escalated versions like hyper-CVAD 1.
  • Rituximab, a monoclonal antibody targeting CD20, is often incorporated into regimens for enhanced efficacy (e.g., R-CHOP) 1.
  • Stem cell transplantation considered for eligible patients in first or subsequent remission 1.

    • Special Populations

  • No specific guidelines provided in the abstracts regarding pregnancy, pediatrics, elderly, or comorbidities 1.

    • Key Recommendations

  • Utilize histopathological examination with immunohistochemistry for definitive diagnosis (Evidence: Strong 1).
  • Incorporate rituximab into chemotherapy regimens for improved outcomes (Evidence: Strong 1).
  • Consider autologous stem cell transplantation for patients achieving remission (Evidence: Moderate 1).

    • References

    1 Baic D, Baic B. A fast method for processing biopsy material for electron microscopy. Ultrastructural pathology 1984. link

    Original source

    1. [1]
      A fast method for processing biopsy material for electron microscopy. — Baic D, Baic B Ultrastructural pathology (1984)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG